Arnold & Porter Again Named to Global Competition Review’s 2026 ‘GCR 100’ Guide

Global Competition Review once again included Arnold & Porter in its annual “GCR 100” guide of law firms and economic consultancies around the world who are “doing the most important antitrust work.” The guide again ranked Arnold & Porter as a “Global Elite” firm for competition law. The firm was also included in the guide’s list of the 10 best private litigation practices, and its international antitrust capabilities and clients were featured in the guide’s regional sections for Brussels, California, New York, and Washington, D.C.

Arnold & Porter’s antitrust/competition practice continues to be recognized worldwide for its breadth and depth of experience and its track record of excellence. Global Competition Review highlighted the firm’s strong docket of work, particularly in the life sciences sector and on the merger control side. The publication lauded the firm’s work advising Novo Nordisk on its $16.5 billion acquisition of Catalent, Boston Scientific on its $3.7 billion acquisition of Axonics, and AbbVie in its $8.7 billion acquisition of Cerevel Therapeutics, among other deals. GCR also highlighted the firm’s work on behalf of Visa in “one of the largest private antitrust litigation portfolios in the US, guiding the company through cases arising from payment card interchange and debit practices.”

Arnold & Porter’s strong understanding of the antitrust agencies, frequent dealings with them, and deep bench of lawyers with senior government experience in the United States and Europe provide the firm with valuable insight and credibility — key elements for clearing deals and addressing criminal and civil conduct investigations. The firm’s antitrust litigators have extensive experience before judges in jurisdictions favored by the antitrust plaintiff's bar and a record of winning before trial, at trial, and on appeal.